FDA Guidance for Industry Long Term Follow-Up After Administration of Human Gene Therapy Products

Titel:
FDA Guidance for Industry Long Term Follow-Up After Administration of Human Gene Therapy Products
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm078719.pdf

Dokumentenart:
Guidance for Industry
Inhalt:
Cellular & Gene Therapy Publications

Zurück

GMP Seminare nach Thema